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Abstract
Background: “Thinner” is a widely used industrial mixture of organic solvents. Exposure to organic solvents is
usually not considered to be a possible cause of epilepsy, despite descriptions of toxic effects on the central
nervous system. There are only a few reports about a possible epileptogenic effect of organic solvents exposure.
We report a case of myoclonic seizure at the workplace that shows a remarkable coincidence between exposure to
a thinner mixture and the occurrence of an epileptic seizure.
Case presentation: We present the case of a 50-year-old Belgian woman exposed to organic solvents for more
than 20 years in a paintbrush manufactory. In 2009, her biological monitoring of hippuric acid (primary urinary
metabolite of toluene) exceeded the threshold limit value of the American Conference of Governmental Industrial
Hygienists.
In 2012, after a period of high organic solvents exposure without the use of proper collective or personal airway
protection, she had a seizure with myoclonic movements of her four limbs and loss of consciousness at her
workplace. An electroencephalogram, computed tomography and magnetic resonance imaging of her head were
within limits. Non-toxicological and toxicological causes were investigated. Her seizures did not reappear after
workplace removal.
Two years after her epileptic insult she was diagnosed with chronic toxic encephalopathy type 2b.
In 2015, volatile organic compounds were measured at her workplace. Multiple (3/18) air samples exceeded the
Belgian time-weighted average over 8 hours (77 mg/m3) for toluene.
Conclusions: Knowledge about the impact of solvent exposure on the occurrence of epileptic insults is lacking.
Long-term exposure to organic solvents is usually not considered to be a possible cause of epileptic seizure. But
epileptic discharges have been described on electroencephalogram recordings for patients with chronic toxic
encephalopathy. Myoclonic encephalopathy has been reported in toxic conditions.
This case emphasizes a possible unusual neurological presentation of occupational exposure to organic solvents. It
may be explained by lowering of the threshold for seizures due to high solvents exposure, most probably by
toluene. This case suggests a chronological connection between a high occupational exposure to solvents and an
epileptic insult. We found no other plausible cause.
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Background
“Thinner” is a widely used industrial volatile liquid, a
mixture of organic solvents (OS), used especially to thin
paint. Toluene is the main component found in com-
mercially available thinners. Exposure to OS is usually
not considered to be a possible cause of epilepsy, despite
descriptions of toxic effects on the central nervous sys-
tem (CNS). We report a case of myoclonic seizure at the
workplace that shows a remarkable coincidence between
the exposure to an OS mixture and the occurrence of an
epileptic seizure. Two years after the insult chronic toxic
encephalopathy (CTE) was diagnosed.
Case presentation
We present the case of a 50-year-old Belgian woman, oc-
cupationally exposed to OS for more than 20 years while
employed at a paintbrush manufactory. At 18 years of age
she was employed at a Belgian dry cleaning service for 6
years, without exposure to perchloroethylene (PER). From
26 years of age, her work tasks involved the use of OS
mixtures and were performed without the use of proper
collective or personal airway protection because her em-
ployer had neither invested in nor provided these prevent-
ive measures. In 2009, the biological monitoring of her
hippuric acid in urine, the primary urinary metabolite of
toluene, demonstrated a value (2540 mg/l) exceeding the
threshold limit value (TLV) of 1600 mg/l of the American
Conference of Governmental Industrial Hygienists [1]. In
October 2012 her work task was removing paint from
wrongly colored paintbrushes manufactured in China.
Shortly after the start of this task, she began to complain
of intense headaches, fatigue, asthenia, irritability, feeling
of drunkenness, sleeping disturbances (sleepiness or, in
contrast, difficulty in falling asleep), nausea, and
paresthesia in her feet. She associated all of these classic
symptoms of acute solvent intoxication with the use of the
OS mixture, a thinner containing a high level of toluene,
with which she worked permanently for over 2 months in
a poorly ventilated work environment. Most symptoms
disappeared during the weekend. She also had visual
perception disturbances (scotomata). On a Thursday
morning, 12 December 2012, she was very confused at her
workplace and had aphasia. This was followed by involun-
tary myoclonic-type movements in all four limbs lasting
for several minutes, she bit her tongue, and a loss of con-
sciousness, possibly with prodromal aura phenomenon.
After the seizures she was confused for a long time, with
disorientation (postictal state). She was transported to a
hospital. On admission, physical and neurologic examina-
tions revealed no abnormalities. A blood count and blood
biochemistry demonstrated normal liver and kidney tests,
no elevated C-reactive protein, slightly elevated D-dimers,
and elevated lactic acid. Unfortunately no toluene levels in
blood were measured. An electrocardiogram (ECG) was
sinusal. Her standard electroencephalogram (EEG) and
brain computed tomography (CT) were within limits. Dif-
ferentiating between cardiogenic or convulsive syncope
and seizure is a diagnostic problem and challenge when
involuntary movements (myoclonic jerks) are involved. In
favor for the diagnosis of seizure were the episode
duration of several minutes and that no arrhythmias were
demonstrated. We found no arguments for triggered
complex migraine and migralepsy before the seizure.
This event was her first epileptic insult. In her medical
history we found a history of migraine, an extra-uterine
pregnancy, female sterilization, and epicondylitis latera-
lis. Many etiological factors were investigated: non-
toxicological and some toxicological (alcohol or any
other addictive substances abuse) causes were excluded.
She did not take or had not recently stopped any medi-
cation. There was no familial history of epilepsy. Further,
there was no history of any disease prenatally, peri-
natally, or in childhood. She did not have and had not
had any psychiatric illness, learning disability, attention
deficit disorder, or a craniocerebral trauma.
She was observed at the hospital for 24 hours. No anti-
epileptic drugs were started because of this first epileptic
episode. Seizures did not reappear after work removal,
although intoxication signs and symptoms remained.
A magnetic resonance imaging (MRI) of her brain per-
formed approximately 2 months after the insult was within
limits. A single-photon emission computed tomography
(SPECT) of her brain did not demonstrate signs of
Alzheimer disease or dementia.
Because some of her signs and symptoms (such as in-
tense headaches, fatigue, asthenia, and irritability) con-
tinued in 2013, she was referred to a neurologist with
expertise in CTE in 2014, who diagnosed that she had
CTE type 2b. Later that same year, she developed a de-
pression secondary to the diagnosis of CTE.
Tests for volatile organic compounds (VOC) at her
workplace were consequently carried out on 19 November
2015. Three out of 18 air samples of different work task
sites at the manufactory exceeded the Belgian time-
weighted average (TWA; 8 hours) of 77 mg/m3 for toluene
(90, 94, and 113 mg/m3). Measurements of 2-butanone, n-
Butyl acetate, ethanol, isobutyl alcohol, and isopropyl alco-
hol did not exceed the Belgian TWA (8 hours).
Discussion
Epilepsy is a condition affecting 2 to 5 % of the world’s
population during their lifetime. Epilepsy is a disorder
with many possible causes. Often a cause cannot be found.
If there is an identifiable cause it usually involves some
form of brain damage. Certain circumstances or sub-
stances can trigger a seizure: stress, lack of sleep, alcohol
(binge drinking, hangover, withdrawal), illegal drugs, fever,
or high temperature. In middle-aged persons epilepsy is
Van Hooste Journal of Medical Case Reports  (2017) 11:36 Page 2 of 4
most likely to be caused by strokes, tumors, or injuries.
The convulsant threshold or seizure threshold is used to
describe the balance between excitatory and inhibitory
forces in the brain which affect the susceptibility of a per-
son to seizures. A reduced seizure threshold is found in 10
% of the human population. This population is at higher
risk of epileptic seizure in the case of exposure to harmful
factors at the workplace or outside it [2]. Medications
such as the antidepressant and nicotinic antagonist bupro-
pion and the atypical opioid analgesics tramadol and
tapentadol can lower the seizure threshold. So can other
factors, including: sleep deprivation; fever; menstruation;
uncontrolled diabetes; lengthy periods of fasting, malnu-
trition, starvation, high stress, fear, fatigue, and exhaustion;
and exposure to flashing or flickering lights. Detection of
the decreased convulsant threshold and gathering know-
ledge about potential epileptogenic factors at workplaces
and in the community environment should become one
of the goals for medical personnel dealing with occupa-
tional problems according to Stankiewicz and Stankiewicz
[3].
There are a few reports about a possible epileptogenic
effect of OS exposure [4–7]. Long-term exposure to OS
is usually not considered a possible cause of epileptic
seizure [8]. In 2002, Viaene reported that knowledge
about the impact of solvent exposure on the occurrence
of epileptic insults or the recurrence rate is lacking [9],
although epileptic discharges have been described on
EEG recordings for patients with CTE type 2b and type
3 [9], and for a worker chronically exposed to thinner
[10]. Bernardini and Scoppetta [4] reported two cases
among painters. The first patient had two generalized
paroxysmal seizures during sleep. The second patient
had acute solvent poisoning followed 7 weeks later with
several epileptic episodes associated with typical EEG
alterations. In both cases there was neither a history of
neurological disease, nor any other neurological dysfunc-
tions. The results of comprehensive neuroradiological
studies were normal. Jacobsen et al. [5] reported the
case of a painter chronically exposed to OS who had
temporal epileptic seizures. Seizures disappeared after
removal from work, and appeared again after exposure
to cyclohexanone, although treated with anti-epileptic
drugs. A case-referent study by Littorin et al. [6] on
focal epilepsy has shown a just significant risk of the
disease in individuals heavily exposed (painters) to OS.
Ginja et al. [7] reported a case of epilepsy in an em-
ployee exposed to PER. Disabling myoclonic encepha-
lopathy has been reported in toxic conditions, for
example after exposure to organic solvent trichloroethyl-
ene [9]. There are also reports of myoclonic encepha-
lopathy in a series of toxic conditions due to: bismuth;
methyl bromide; manganese; lead; mercury; colloidal
silver; rodenticides containing alpha-chloralose; drugs
such as dopa, lamotrigine, carisoprodol, cefuroxime and
lithium; and mushroom ingestion [2].
Our literature review resulted in some animal studies
[11–13] about seizures, convulsions, epilepsy, in association
with exposure to solvents [4–8]. OS comprise chemically
heterogeneous compounds, with a widespread application
in a range of occupational settings and industries. Their
volatility and lipophilicity make OS toxicologically import-
ant. OS rapidly contaminate the work environment and
pose a major health risk in occupational settings. Solvents,
or reactive metabolites, result in long-term health effects.
Exposure mainly occurs through inhalation and skin con-
tact. Owing to their lipophilic and hydrophilic properties,
exposure affects the CNS. The neurotoxic effects are well
known in occupational exposure occurring in poor indus-
trial hygiene conditions [4] Toluene is the main agent
found in commercially available thinners. Toluene is a
hydrocarbon solvent that is insoluble in water. After inhal-
ation it is absorbed by the lungs and bound to lipopro-
teins. The main toxic impact of toluene is on the CNS,
probably explained by high cerebral perfusion and the af-
finity of toluene for lipid-rich tissues, from which it is
slowly released [14]. The effect on the CNS may be de-
pressant or excitatory, with euphoria in the induction
phase followed by disorientation, tremulousness, mood la-
bility, tinnitus, diplopia, hallucinations, dysarthria, ataxia,
convulsions, and coma. A review by Yücel et al. [15] indi-
cated that toluene preferentially affects white matter struc-
tures, periventricular regions, and subcortical regions.
More evidence suggests the possibility for some sub-
cortical structures to initiate seizures independently.
Findings from histopathologic, electrophysiologic, and
brain imaging studies provide ample evidence demon-
strating that like normal cerebral function, epileptic sei-
zures involve widespread network interactions between
cortical and subcortical structures. Different forms of
generalized and focal epileptiform discharges and sei-
zures engage various subcortical structures in varying
ways [16].
Conclusions
In conclusion, we have reported the case of a patient
with a myoclonic seizure probably induced by OS poi-
soning. This case suggests a possible unusual neuro-
logical presentation of occupational exposure to OS.
This case suggests a chronological connection between a
high occupational exposure to solvents and an epileptic
insult, but it is not possible to identify a definite causal
relationship (anecdotal evidence because it is retrospec-
tive and not controlled) [17]. Animal data support the
causal association of this biologically plausible event. We
found no other plausible cause other than the acute and
chronic high OS exposure.
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